These researchers do not know me or my seven Babesisa books, but five years before this article we found that artesunate is an excellent Babesia killer. As we published in 2023, artesunate is FDA-approved as a $1000 100mg iv injection for neurological malaria.
The dosing is variable, but 1/8-1/4th of a 200mg, with an increase every few days to a week.
Availability exists in many nations. Some have it to buy, and others do not.
We] studied the effects of artesunate, a water-soluble [medivation], against Babesia species, including *Babesia bovis*, *Babesia gibsoni*, and *Babesia microti*. Cultures of B. bovis and B. gibsoni were treated with 0.26, 2.6, 26 and 260 µM artesunate, showing inhibition of parasite growth at concentrations equal to and greater than 2.6microM artesunate by days 3 post-treatment for B. gibsoni and B. bovis in a dose-dependent manner.
Consistent with in vitro experiments, artesunate effectively treated mice infected with B. microti at doses equal to or greater than 10mg/kg of body weight on days 8-10 post-infection. Taken together, these results suggest that artesunate could be a potential drug against Babesia infection.
Goo YK, Terkawi MA, Jia H, Aboge GO, Ooka H, Nelson B, Kim S, Sunaga F, Namikawa K, Igarashi I, Nishikawa Y, Xuan X. Artesunate, a potential drug for treatment of Babesia infection. Parasitol Int. 2010 Sep;59(3):481-6. doi: 10.1016/j.parint.2010.06.004. Epub 2010 Jun 9. PMID: 20541037.
